Bibliographic information
GuidelineUse of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing: interim guidance, 9 March 2022.
Year of Publication2022
Issuing InstitutionWHO
Recommendation
Maintained
Originally developed
COVID-19 self-testing, using SARS-CoV-2 antigen-detection rapid diagnostic tests (Ag-RDTs), should be offered in addition to professionally administered testing services
Recommended in favor
Strong
Certainty of evidence
Low
Notes and Remarks
Remarks:
- Human rights: COVID-19 self-testing is a personal choice. It can expand access to testing by providing an additional way for people to test and make personal risk-based decisions that may affect their health and the health of their families and communities (e.g. to protect those most affected by or who may be at increased risk of severe COVID-19, or to enable individual participation in activities). COVID-19 self-testing, as with any testing, should always be voluntary and never mandatory or coercive. The practice of self-testing, regardless of test results, must always be free from stigma and discrimination. Self-testers will need to be provided with adequate information on when to test and nationally-relevant post-test responsibilities and actions. Anyone uncertain of their COVID-19 self-testing result, or desiring alternative professional testing services, should be encouraged to access other testing options where available and in line with the latest national guidance. Countries should consider reviewing and contextualizing their existing policies on the age of consent to include COVID-19 self-testing and the role of assisted and caregiver-led self-testing by a parent or guardian. For adolescents and mature minors, age-of-consent policies that enable access without parental consent are important to enable COVID-19 self-testing when needed.
- Epidemiology: The implications of a test result are not only a function of its inherent sensitivity and specificity. The result is also dependent on the prevalence of SARS-CoV-2 infection in the population prioritized for testing. When using COVID-19 self-testing in settings with higher pre-test probability i.e., higher likelihood of an individual having SARS-CoV-2 infection, such as in places where there is ongoing community transmission or when an individual is at high likelihood of exposure (e.g. contacts, health and care workers)–the positive predictive value of the test is high. This means a positive self-testing result is likely to be a true positive. When COVID-19 self-testing is used in a low pre-test probability setting (e.g. when testing someone without symptoms and no known exposure to the virus or when there is no or low community transmission), the positive predictive value of self-testing is lower, which will lead to increased false-positive results. In these situations, the negative predictive value of COVID-19 self-testing is high, meaning the risk of a false negative is lower. Policymakers and implementers need to consider reasons for testing and evolving epidemiology when COVID-19 self-testing is offered along with other testing approaches. Clear and up-to-date messaging will need to be provided to health workers, individuals and communities so that self-testers can understand the meaning of their test results and what actions to take post-test. See WHO guidelines on COVID-19 transmission scenarios, public health and social measures, and public health surveillance for COVID-19, including up-to-date definitions of contacts and cases for further details (15-18).
- Evolving context, priorities and messaging: Health worker and community awareness of and engagement in adapting COVID-19 self-testing is important for successful implementation. As local epidemiology changes, information on self-testing that is context-specific, correct, clear, concise and age-appropriate should be made available. Messaging should include when self-testing should be prioritized or deprioritized for specific populations or settings, the meaning of a positive or negative self-test result and any recommended follow-up actions after selftesting. Messages will vary based on current local situations but should be consistent with national policies. They may include information on result reporting (17), quarantine (19), contact tracing (18, 20), when to seek confirmatory testing and retesting (1), availability of treatment services (21, 22), and latest information on infection prevention and control, masking and physical distancing (23-26) and public health and social measures (15, 16).
- Emerging SARS-CoV-2 variants: This recommendation is valid for detection of all reported SARS-CoV-2 variants of concern (27). As SARS-CoV-2 continues to evolve, policies will need to take into consideration circulating variants and test performance. The accuracy of COVID-19 self-testing needs to be continually assessed and reviewed with the emergence and spread of new variants, just as it is for professional-use NAAT and Ag-RDT.
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Clinical management of COVID-19: living guideline, 23 June 2022.
Year2022
InstitutionWHO
Guideline
Clinical management of COVID-19: living guideline, 15 September 2022.
Year2022
InstitutionWHO
Guideline
Clinical management of COVID-19: living guideline, 13 January 2023.
Year2023
InstitutionWHO
Guideline
Clinical management of COVID-19: living guideline, 18 August 2023
Year2023
InstitutionWHO
Guideline
Clinical management of COVID-19: living guideline, June 2025
Year2025
InstitutionWorld Health Organization